mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |